This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
KIDSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Huntsman (HUN): Can Its 5.6% Jump Turn into More Strength?
by Zacks Equity Research
Huntsman (HUN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
HUNNegative Net Change CMPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Outbrain (OB) Surges 7.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Outbrain (OB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RIOTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
DigitalOcean (DOCN) Surges 5.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
DigitalOcean (DOCN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
DOCNNegative Net Change SNCRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BigBear.ai (BBAI) Soars 44.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
BigBear.ai (BBAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BBAINegative Net Change UISPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Embraer (ERJ) Soars 14.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Embraer (ERJ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ERJPositive Net Change LUNRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Blueprint Medicines (BPMC) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
IREN Limited (IREN) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
IRENNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
BellRing Brands (BRBR) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
BRBRNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
BellRing Brands (BRBR) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
BRBRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Greenbrier Companies (GBX) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
GBXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength?
by Zacks Equity Research
Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
DNAPositive Net Change KRYSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Radcom (RDCM) Moves 14.5% Higher: Will This Strength Last?
by Zacks Equity Research
Radcom (RDCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RDCMPositive Net Change CSCONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ceragon (CRNT) Soars 11.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Ceragon (CRNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRNTPositive Net Change AMXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beyond (BYON) Surges 33.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Beyond (BYON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BYONPositive Net Change CPNGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Pacira (PCRX) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PCRXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pure Storage (PSTG) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
PSTGPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Frontdoor (FTDR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
FTDRNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?
by Zacks Equity Research
Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
STOKPositive Net Change ANIKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
by Zacks Equity Research
Exagen (XGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
XGNPositive Net Change CAPRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
MP Materials (MP) Soars 10.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
MP Materials (MP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MPPositive Net Change CLFNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
GDS Holdings (GDS) Moves 18.3% Higher: Will This Strength Last?
by Zacks Equity Research
GDS Holdings (GDS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GDSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Kingsoft Cloud (KC) Moves 20.5% Higher: Will This Strength Last?
by Zacks Equity Research
Kingsoft Cloud (KC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KCNegative Net Change REKRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PTCTPositive Net Change ALGSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Tempur Sealy (TPX): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
Tempur Sealy (TPX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
TPXNegative Net Change HDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today